MOWANA Auto Duo
PENTAMASTER MEDIQ SDN BHD · Decision date Sep 17, 2026
What did the FDA decide?
The FDA recorded a substantially equivalent (SESE) decision on September 17, 2026 for MOWANA™ Auto Duo, submitted by PENTAMASTER MEDIQ SDN BHD of Simpang Ampat, Malaysia, under 510(k) number K261266. The device falls under the classification name Needle, Hypodermic, Single Lumen, regulation number 880.5570, product code FMI, with a General Hospital medical specialty and review panel. The application was received April 16, 2026, and was reviewed by a third party; the record lists it as a traditional 510(k), not a combination product, with no authorized Predetermined Change Control Plan.
SESE means the submission was cleared as substantially equivalent; it is not a PMA approval. The record does not describe the specific components, design features, or any changed item, and no summary statement is present in the supplied data. The correspondence is addressed to Dave Yungvirt, CEO of Third Party Review Group, LLC, in Henderson, Nevada, while the applicant contact is listed as Thean Lye Ong. Details of the predicate comparison and the basis for the equivalence determination remain outside the provided material.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General Hospital
- Decision date
- Sep 17, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261266
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- PENTAMASTER MEDIQ SDN BHD
- Product code
- FMI
- Decision code
- SESE
- Decision date
- Sep 17, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Needle, Hypodermic, Single Lumen.
- Applicant
- PENTAMASTER MEDIQ SDN BHD
- Product code
- FMI
- FDA device class
- 2
FDA decision timeline
K261266 received
Application receipt date recorded by FDA.
K261266 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
PENTAMASTER MEDIQ SDN BHD
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Simpang Ampat
Sources and methodology
- Original FDA record: K261266
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records